SPONSOR
Peking Union Medical College Hospital
Total Trials
6
Recruiting
6
Phases
EARLY_Phase 1, Phase 2
Conditions studied: SSTR2 and Integrin αVβ3 Positive TumorsCadonilimab and LenvatinibAutoimmune DiseasesAutoinflammatory DiseasesHPVHIV InfectionsVaginal MicrobiotaPancreatic CancerResectable CarcinomaBiliary Tract Cancer
Peking Union Medical College Hospital is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including SSTR2 and Integrin αVβ3 Positive Tumors, Cadonilimab and Lenvatinib, Autoimmune Diseases, Autoinflammatory Diseases.
The trial portfolio spans EARLY_Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peking Union Medical College Hospital
How many clinical trials has Peking Union Medical College Hospital sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Peking Union Medical College Hospital, of which 6 are actively recruiting participants. These trials cover conditions including SSTR2 and Integrin αVβ3 Positive Tumors, Cadonilimab and Lenvatinib, Autoimmune Diseases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peking Union Medical College Hospital research focus on?
Peking Union Medical College Hospital clinical trials span SSTR2 and Integrin αVβ3 Positive Tumors, Cadonilimab and Lenvatinib, Autoimmune Diseases, Autoinflammatory Diseases, HPV, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peking Union Medical College Hospital clinical trial?
To participate in a Peking Union Medical College Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking Union Medical College Hospital trials with current recruitment status updated daily.
Clinical Trials by Peking Union Medical College Hospital
NCT06632873 EARLY_Phase 1
Recruiting
177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors
SSTR2 and Integrin αVβ3 Positive Tumors
NCT06215651 Phase 2
Recruiting
Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma
Cadonilimab and Lenvatinib
NCT06417502
Recruiting
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Autoimmune Diseases
NCT05996016
Recruiting
Gut and Vaginal Microbiota Profile Study for HIV Women
HPV
NCT05802407
Recruiting
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer
Pancreatic Cancer
NCT07267078 Phase 2
Recruiting
Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer
Biliary Tract Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology